Hospitals and health systems engaged in clinical trials enjoy several benefits — the ability to provide the latest treatment options to patients, the prestige of being a research organization, as well ...

These projects are not only about adding beds or buildings; they represent a broader effort to bring advanced care, clinical ...

Together, the panelists discussed the multifaceted challenges that rural communities face in accessing clinical trials and offered actionable strategies to overcome these barriers. Breaking Down ...

Please provide your email address to receive an email when new articles are posted on . JAMA+ Trials is intended to invigorate dialogue about trials and showcase the effort behind them, its editor in ...

Patients today are more involved in their healthcare choices than ever before, and gaining access to accurate, relevant and easily understandable information can help empower them to make more ...

Clinical trials offer a pathway to innovative treatments while driving medical progress. Knowing how to search, qualify, and enroll empowers you to make safe, informed choices. This guide walks you ...

More flexibility in early-phase development for cell therapies is needed, a panel of US Food and Drug Administration (FDA) ...

Among the many catchphrases of the Affordable Care Act individual mandates, pre-existing conditions clinical trials is one that has flown under the radar. But in terms of immediate impact, it is one ...

Digital databases for clinical trial searches have already changed healthcare accessibility, bringing critical information about clinical trials to the patients who need it – and to the physicians who ...

A cancer diagnosis presents patients with complex treatment decisions. While traditional therapies like surgery, chemotherapy, and radiation remain standard options, clinical trials offer additional ...

This course provides an overview of the foundation for clinical trials in the US including their historical evolution, ethical conduct and regulations and the responsibilities of parties involved in ...

Doctronic reports that Foundayo, an oral GLP-1 for diabetes, shows promise but lacks long-term safety data beyond 68 weeks; ...